Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov 18;11(11):2143.
doi: 10.3390/diagnostics11112143.

Serum Biomarkers in Carotid Artery Disease

Affiliations
Review

Serum Biomarkers in Carotid Artery Disease

Vassiliki I Kigka et al. Diagnostics (Basel). .

Abstract

Carotid artery disease is considered a major cause of strokes and there is a need for early disease detection and management. Although imaging techniques have been developed for the diagnosis of carotid artery disease and different imaging-based markers have been proposed for the characterization of atherosclerotic plaques, there is still need for a definition of high-risk plaques in asymptomatic patients who may benefit from surgical intervention. Measurement of circulating biomarkers is a promising method to assist in patient-specific disease management, but the lack of robust clinical evidence limits their use as a standard of care. The purpose of this review paper is to present circulating biomarkers related to carotid artery diagnosis and prognosis, which are mainly provided by statistical-based clinical studies. The result of our investigation showed that typical well-established inflammatory biomarkers and biomarkers related to patient lipid profiles are associated with carotid artery disease. In addition to this, more specialized types of biomarkers, such as endothelial and cell adhesion, matrix degrading, and metabolic biomarkers seem to be associated with different carotid artery disease outputs, assisting vascular specialists in selecting patients at high risk for stroke and in need of intervention.

Keywords: atherosclerosis; carotid artery disease; carotid stenosis; plaque vulnerability; risk stratification; serum biomarkers; ultrasound.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Saenger A.K., Christenson R.H. Stroke biomarkers: Progress and challenges for diagnosis, prognosis, differentiation, and treatment. Clin. Chem. 2010;56:21–33. doi: 10.1373/clinchem.2009.133801. - DOI - PubMed
    1. Virani S.S., Alonso A., Benjamin E.J., Bittencourt M.S., Callaway C.W., Carson A.P., Chamberlain A.M., Chang A.R., Cheng S., Delling F.N., et al. Heart disease and stroke statistics—2020 update: A report from the American Heart Association. Circulation. 2020;141:e139–e596. doi: 10.1161/CIR.0000000000000757. - DOI - PubMed
    1. Messas E., Goudot G., Halliday A., Sitruk J., Mirault T., Khider L., Saldmann F., Mazzolai L., Abyans V. Management of carotid stenosis for primary and secondary prevention of stroke: State-of-the-art 2020: A critical review. Eur. Heart J. Suppl. 2020;22:M35–M42. doi: 10.1093/eurheartj/suaa162. - DOI - PMC - PubMed
    1. Vlachopoulos C., Xaplanteris P., Aboyans V., Brodmann M., Cífková R., Cosentino F., De Carlo M., Gallino A., Landmesser U., Laurent S., et al. The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society. Atherosclerosis. 2015;241:507–532. - PubMed
    1. Hermus L., Lefrandt J.D., Tio R.A., Breek J.-C., Zeebregts C.J. Carotid plaque formation and serum biomarkers. Atherosclerosis. 2010;213:21–29. doi: 10.1016/j.atherosclerosis.2010.05.013. - DOI - PubMed

LinkOut - more resources